Publication | Closed Access

Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies

Combinatorial ChemistryMedicinal ChemistryPotential Pcaf InhibitorsMedicineVitro Anticancer EvaluationPharmacotherapyNovel Triazolophthalazine-hydrazone HybridsAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery